| 5th Nov 2025 7:01 am |
RNS |
£250,000 Convertible Loan Note Issue |
| 5th Nov 2025 7:00 am |
RNS |
LOI with leading UK Clinical Diagnostic Group |
| 27th Oct 2025 11:32 am |
RNS |
Change of Registered Office |
| 30th Sep 2025 7:00 am |
RNS |
Interim Results |
| 29th Sep 2025 7:00 am |
RNS |
Update on Clinical Laboratory Partnerships in USA |
| 18th Aug 2025 7:00 am |
RNS |
Commercial Progress in USA |
| 30th Jun 2025 1:45 pm |
RNS |
Result of AGM |
| 6th Jun 2025 11:00 am |
RNS |
Notice of AGM |
| 28th May 2025 7:00 am |
RNS |
Holding(s) in Company |
| 20th May 2025 7:00 am |
RNS |
£150,000 Convertible Loan Note Issue |
| 30th Apr 2025 11:18 am |
RNS |
Final results for the year ended 31 December 2024 |
| 28th Apr 2025 7:00 am |
RNS |
Contract in Caribbean and Update on CIZ1B |
| 14th Apr 2025 10:00 am |
RNS-R |
Launch of New Website |
| 25th Mar 2025 7:00 am |
RNS |
Appointment of Non-Executive Director |
| 24th Mar 2025 7:00 am |
RNS |
Update on Launch of CIZ1B Biomarker Assay |
| 2nd Jan 2025 7:00 am |
RNS |
Appointment of Professor Dawn Coverley as CSO |
| 16th Dec 2024 7:00 am |
RNS |
Update on Strategic Partnership in North America |
| 21st Oct 2024 7:00 am |
RNS |
Execution of Agreement for North America |
| 3rd Oct 2024 1:12 pm |
RNS |
Update on Licensing and Partnership Agreement |
| 30th Sep 2024 7:00 am |
RNS |
Interim Results |
| 16th Sep 2024 7:00 am |
RNS |
Holding(s) in Company |
| 9th Sep 2024 7:00 am |
RNS |
Collaboration with Moffitt Cancer Center |
| 25th Jul 2024 7:00 am |
RNS |
Update on Strategic Partnership in North America |
| 18th Jul 2024 7:00 am |
RNS |
Manufacturing Agreement with BBI Solutions |
| 9th Jul 2024 7:00 am |
RNS |
Issue of Share Options in Lieu of Consultancy Fees |
| 24th Jun 2024 12:42 pm |
RNS |
Result of AGM |
| 17th Jun 2024 7:00 am |
RNS |
Update on North American Strategic Licensing MoU |
| 3rd Jun 2024 7:00 am |
RNS |
Notice of Annual General Meeting |
| 13th May 2024 7:00 am |
RNS |
Holding(s) in Company |
| 30th Apr 2024 5:00 pm |
RNS |
Total Voting Rights |
| 30th Apr 2024 9:12 am |
RNS |
Final results for the year ended 31 December 2023 |
| 23rd Apr 2024 11:20 am |
RNS |
Holding(s) in Company |
| 2nd Apr 2024 7:00 am |
RNS |
Licensing and Partnership MoU for North America |
| 26th Mar 2024 7:00 am |
RNS |
Placing to raise £0.62 million |
| 28th Sep 2023 7:00 am |
RNS |
Interim Results |
| 21st Sep 2023 7:00 am |
RNS |
Update on Put Option with Conduit |
| 19th Sep 2023 7:00 am |
RNS |
Completion of Evaluation Programme with Bio-Techne |
| 8th Sep 2023 7:03 am |
RNS |
Extension of and update on Put Option with Conduit |
| 15th Aug 2023 7:00 am |
RNS |
Update on Put Option with Conduit |
| 10th Aug 2023 7:00 am |
RNS |
Expansion of Research Agreement and CIZ1B Update |
